Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
new york blog main
alirocumab
alnylam pharmaceuticals
amgen
boston
cancer
codiak biosciences
cutaneous t-cell lymphoma
deals
evolocumab
exosome
fda
inclisiran
jazz pharmaceuticals
national top stories
new york
new york top stories
novartis
pcsk9
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
sanofi
sarepta therapeutics
the medicines company
What
brings
2
×
medicines
2
×
new
2
×
acquire
agreed
based
begin
billion
biosciences
bio’s
bubbles
cash
cells
cholesterol
class
clinical
codiak
company
compound
deal
drug
exosome
exosomes
fda
formed
fund
ipo
medco
million
novartis
poised
ready
tests
tiny
trials
wave
Language
unset
Current search:
brings
×
biotech
×
medicines
×
new
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B